Literature DB >> 29707554

Comparison of minimally invasive and open transforaminal lumbar interbody fusion in the treatment of single segmental lumbar spondylolisthesis: minimum two-year follow up.

Ai-Min Wu1,2, Zhi-Chao Hu1, Xiao-Bin Li1, Zhen-Hua Feng1, Dong Chen1, Hui Xu1, Qi-Shan Huang1, Yan Lin1, Xiang-Yang Wang1, Kai Zhang2, Jie Zhao2, Wen-Fei Ni1.   

Abstract

BACKGROUND: Compare the efficacy and safety of minimally invasive and open transforaminal lumbar interbody fusion (TLIF) in the treatment of single segmental lumbar spondylolisthesis.
METHODS: From 2010-01 to 2015-10, in total, 167 patients with single segmental spondylolisthesis treated by TLIF were included, 79 cases in minimally invasive TLIF (MI-TLIF) group and 88 cases in open TLIF group. The peri-operative parameters of operative time, estimated blood loss and length of postoperative hospital stay was recorded, as well as complications. Visual Analogue Scale (VAS) of low back pain and leg pain, and Oswestry Disability Index (ODI) were used to assess the pain and functional outcomes at pre-operatively, 3 months/1 year/2 years/5 years after operation. The radiographic parameters of posterior height of the intervertebral space and segmental lordosis were measured too.
RESULTS: No significantly difference was found at baseline characteristic data of age, gender ratio, the percentage of degenerative and isthmic spondylolisthesis, the percentage of slip, and segmental distribution between MI-TLIF and open TLIF groups. MI-TLIF group had less estimated intra-operative blood loss (163.7±49.6 mL) than open TLIF group (243.3±70.2 mL, P<0.001) and had shorter post-operative hospital stay (5.8±1.4 days) than open TLIF group (7.3±2.9 days, P<0.001). Both MI-TLIF and open TLIF can significantly reduce the VAS of low back pain, VAS of leg pain, ODI, and improve the posterior height of the intervertebral space and segmental lordosis, but no significantly difference was found of them between two groups.
CONCLUSIONS: Our study suggests that MI-TLIF is a safe and effective choice in the treatment of lower grade lumbar spondylolisthesis (grade II or less), and it has advantages of less blood loss, postoperative hospital stay when compared to open TLIF.

Entities:  

Keywords:  Minimally invasive; lumbar spondylolisthesis; lumbar stenosis; transforaminal lumbar interbody fusion (TLIF)

Year:  2018        PMID: 29707554      PMCID: PMC5900072          DOI: 10.21037/atm.2018.02.11

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  31 in total

Review 1.  Minimally invasive transforaminal lumbar interbody fusion: a review of techniques and outcomes.

Authors:  Isaac O Karikari; Robert E Isaacs
Journal:  Spine (Phila Pa 1976)       Date:  2010-12-15       Impact factor: 3.468

2.  The surgical management of degenerative lumbar spondylolisthesis: a systematic review.

Authors:  C Ryan Martin; Adam T Gruszczynski; Heike A Braunsfurth; Salah M Fallatah; Joseph O'Neil; Eugene K Wai
Journal:  Spine (Phila Pa 1976)       Date:  2007-07-15       Impact factor: 3.468

3.  Fusion in degenerative spondylolisthesis: how to reconcile conflicting evidence.

Authors:  Adam M Pearson
Journal:  J Spine Surg       Date:  2016-06

Review 4.  Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF.

Authors:  Ralph J Mobbs; Kevin Phan; Greg Malham; Kevin Seex; Prashanth J Rao
Journal:  J Spine Surg       Date:  2015-12

5.  Effect and possible mechanism of muscle-splitting approach on multifidus muscle injury and atrophy after posterior lumbar spine surgery.

Authors:  Zhi-Jun Hu; Xiang-Qian Fang; Zhi-Jie Zhou; Ji-Ying Wang; Feng-Dong Zhao; Shun-Wu Fan
Journal:  J Bone Joint Surg Am       Date:  2013-12-18       Impact factor: 5.284

Review 6.  Minimally invasive versus open transforaminal lumbar interbody fusion for treatment of degenerative lumbar disease: systematic review and meta-analysis.

Authors:  Kevin Phan; Prashanth J Rao; Andrew C Kam; Ralph J Mobbs
Journal:  Eur Spine J       Date:  2015-03-27       Impact factor: 3.134

Review 7.  Management of lumbar spinal stenosis.

Authors:  Jon Lurie; Christy Tomkins-Lane
Journal:  BMJ       Date:  2016-01-04

8.  Serial changes in trunk muscle performance after posterior lumbar surgery.

Authors:  R Gejo; H Matsui; Y Kawaguchi; H Ishihara; H Tsuji
Journal:  Spine (Phila Pa 1976)       Date:  1999-05-15       Impact factor: 3.468

9.  Comparison of one-level minimally invasive and open transforaminal lumbar interbody fusion in degenerative and isthmic spondylolisthesis grades 1 and 2.

Authors:  Jian Wang; Yue Zhou; Zheng Feng Zhang; Chang Qing Li; Wen Jie Zheng; Jie Liu
Journal:  Eur Spine J       Date:  2010-04-22       Impact factor: 3.134

10.  Increased low back pain prevalence in females than in males after menopause age: evidences based on synthetic literature review.

Authors:  Yì Xiáng J Wáng; Jùn-Qīng Wáng; Zoltán Káplár
Journal:  Quant Imaging Med Surg       Date:  2016-04
View more
  9 in total

1.  The compression of L5 nerve root, single or double sites?-radiographic graded signs, intra-operative detect technique and clinical outcomes.

Authors:  Ai-Min Wu; Kai Zhang; Xun-Lin Li; Xiao-Fei Cheng; Tang-Jun Zhou; Lin Du; Chen Chen; Hai-Jun Tian; Xiao-Jiang Sun; Chang-Qing Zhao; Yan Michael Li; Jie Zhao
Journal:  Quant Imaging Med Surg       Date:  2018-05

2.  MIS-TLIF versus O-TLIF for single-level degenerative stenosis: study protocol for randomised controlled trial.

Authors:  Olga N Leonova; Evgeny A Cherepanov; Aleksandr V Krutko
Journal:  BMJ Open       Date:  2021-03-05       Impact factor: 2.692

3.  Optimal medial transforaminal lumbar interbody fusion approach with five extensive options: A simulated study on three-dimensional digital reconstructed images.

Authors:  Ai-Min Wu; Xun-Lin Li; Hai-Jun Tian; Kai Zhang; Chang-Qing Zhao; Sun-Ren Sheng; Yan Lin; Wen-Fei Ni; Xiang-Yang Wang; Jie Zhao
Journal:  J Orthop Translat       Date:  2018-08-06       Impact factor: 5.191

4.  Initial stability of one-stage anterior debridement and cage implantation combined with anterior-lateral fixation by a dual screw-rod construct in the treatment of lumbosacral tuberculosis: a cadaveric biomechanical study.

Authors:  Jiantao Liu; Yanzheng Gao; Zhengchao Gao; Binbin Niu; Dongbo Lv; Yin Yang
Journal:  BMC Musculoskelet Disord       Date:  2019-05-10       Impact factor: 2.362

5.  Minimally Invasive Transforaminal Lumbar Interbody Fusion for the Surgical Management of Post-Discectomy Syndrome.

Authors:  Ahmed Bahaa Al Din AlShazli; Ashraf Yassin Amer; Ahmed Maher Sultan; Ahmed Samir Barakat; Wael Koptan; Yasser ElMiligui; Hesham Shaker
Journal:  Asian Spine J       Date:  2019-11-08

6.  Risk factors of postoperative low back pain for low-grade isthmic spondylolisthesis: a retrospective study.

Authors:  Fulin Guan; Hongna Yin; Lin Zhu; Zhizhuang Zhang; Qichang Gao; Tuo Shao; Weilong Tang; Guofa Guan; Ming Chen; Zhiyong Chi; Jiaao Gu; Zhange Yu
Journal:  J Int Med Res       Date:  2019-12-18       Impact factor: 1.671

7.  Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: Technique Note and Comparison of Early Outcomes with Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spondylolisthesis.

Authors:  Hao Zhang; Chuanli Zhou; Chao Wang; Kai Zhu; Qihao Tu; Meng Kong; Chong Zhao; Xuexiao Ma
Journal:  Int J Gen Med       Date:  2021-02-22

8.  Clinical outcomes, complications and fusion rates in endoscopic assisted intraforaminal lumbar interbody fusion (iLIF) versus minimally invasive transforaminal lumbar interbody fusion (MI-TLIF): systematic review and meta-analysis.

Authors:  José Miguel Sousa; Hugo Ribeiro; João Luís Silva; Paulo Nogueira; José Guimarães Consciência
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

9.  An updated meta-analysis of clinical outcomes comparing minimally invasive with open transforaminal lumbar interbody fusion in patients with degenerative lumbar diseases.

Authors:  Ying-Chun Chen; Lin Zhang; Er-Nan Li; Li-Xiang Ding; Gen-Ai Zhang; Yu Hou; Wei Yuan
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.